Cargando…

Emerging Therapeutic Agents for Colorectal Cancer

There are promising new therapeutic agents for CRC patients, including novel small-molecule inhibitors and immune checkpoint blockers. We focused on emerging CRC’s therapeutic agents that have shown the potential for progress in clinical practice. This review provides an overview of tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalli, Marianna, Puxeddu, Michela, La Regina, Giuseppe, Gianni, Stefano, Silvestri, Romano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707340/ https://www.ncbi.nlm.nih.gov/pubmed/34946546 http://dx.doi.org/10.3390/molecules26247463

Ejemplares similares

Emerging Direct Targeting β-Catenin Agents
por: Nalli, Marianna, et al.
Publicado: (2022)

Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer
por: Nardella, Caterina, et al.
Publicado: (2021)

Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
por: Masci, Domiziana, et al.
Publicado: (2023)

Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of Resistance
por: Van Dycke, Jana, et al.
Publicado: (2021)

Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents
por: Coluccia, Antonio, et al.
Publicado: (2019)

Targeting the Interaction between the SH3 Domain of Grb2 and Gab2
por: Malagrinò, Francesca, et al.
Publicado: (2020)

A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet Formulations
por: Mammone, Francesca Romana, et al.
Publicado: (2023)

Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor
por: Puxeddu, Michela, et al.
Publicado: (2022)

Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor
por: Coluccia, Antonio, et al.
Publicado: (2022)

Emerging therapeutic agents for lung cancer
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2016)

Emerging therapeutic agents for genitourinary cancers
por: Zarrabi, Kevin, et al.
Publicado: (2019)

4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells
por: Masci, Domiziana, et al.
Publicado: (2023)

Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
por: Bufano, Marianna, et al.
Publicado: (2020)

Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer
por: Schwarzmueller, Laura, et al.
Publicado: (2020)

N-Pyrrylarylsulfones with High Therapeutic Potential
por: Famiglini, Valeria, et al.
Publicado: (2017)

Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
por: Silva, Valdenizia R., et al.
Publicado: (2021)

Emerging therapeutic agents for advanced non-small cell lung cancer
por: Chen, Ruqin, et al.
Publicado: (2020)

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
por: Bignucolo, Alessia, et al.
Publicado: (2017)

Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
por: Kumar, Anil, et al.
Publicado: (2023)

New and emerging therapeutic agents for the treatment of fibromyalgia: an update
por: Recla, Jill M
Publicado: (2010)

Extracellular vesicles: Emerging tools as therapeutic agent carriers
por: Liu, Shan, et al.
Publicado: (2022)

Emergence of taurine as a therapeutic agent for neurological disorders
por: Jangra, Ashok, et al.
Publicado: (2023)

Therapeutic strategies in Crohn’s disease in an emergency surgical setting
por: Chiarello, Maria Michela, et al.
Publicado: (2022)

Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
por: Gallo, Gaetano, et al.
Publicado: (2021)

Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
por: Zhong, Xinyang, et al.
Publicado: (2022)

β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy
por: Saponaro, Concetta, et al.
Publicado: (2018)

Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
por: Singh, Manish Pratap, et al.
Publicado: (2019)

Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis
por: Hosten, Terron Anthony, et al.
Publicado: (2014)

Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?
por: De Martino, Viviana, et al.
Publicado: (2021)

Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
por: Athar, Teeba, et al.
Publicado: (2021)

Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
por: Wilton, Steve D, et al.
Publicado: (2011)

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
por: Zhang, Yiyin, et al.
Publicado: (2018)

Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents
por: Khoshnam, Seyed Esmaeil, et al.
Publicado: (2017)

Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy
por: Rosati, Gerardo, et al.
Publicado: (2022)

Significance of Infectious Agents in Colorectal Cancer Development
por: Antonic, Vlado, et al.
Publicado: (2013)

Epigenetic Modulators as Therapeutic Agents in Cancer
por: Patnaik, Eshaan, et al.
Publicado: (2023)

Emerging Roles for the RNA-Binding Protein HuD (ELAVL4) in Nervous System Diseases
por: Silvestri, Beatrice, et al.
Publicado: (2022)

Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy
por: Koch, Regina M., et al.
Publicado: (2021)

Squamous cell anal cancer: Management and therapeutic options
por: Pessia, Beatrice, et al.
Publicado: (2020)

Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B
por: Pippa, Simone, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0jd02m160jckbjbeouvj4o0r3g